Transforming glaucoma care with next-generation therapies
Gene Therapy: Protecting Sight at the Source
Our gene therapy technology offers a promising approach to treating glaucoma by targeting the underlying causes of vision loss rather than just managing symptoms. By delivering protective genes or silencing harmful ones, this therapy can help protect retinal ganglion cells from damage and preserve eyesight. Unlike conventional treatments, gene therapy has the potential to provide long-lasting benefits.
Precision Nanodelivery for Glaucoma
Our technology uses advanced nanodelivery systems to precisely target key cells that carry visual information to the brain such as retinal ganglion cells. By delivering therapeutic drugs or CRISPR gene-editing tools directly to these cells, we offer a powerful new approach to treating glaucoma, one of the leading causes of irreversible blindness. This targeted precision not only improves the effectiveness of therapies but also reduces unwanted side effects, protecting vision where it matters most.
Smart Delivery: From Eye Drop to Retina
our nanoparticles can travel from a simple eye drop all the way to target cells in the retina, overcoming natural barriers that have long limited treatment options. This non-invasive innovation enables both drugs and gene-editing tools to reach the very cells responsible for vision, unlocking transformative therapies for glaucoma and other sight-threatening diseases.